$90.74 (0.699%)

Volume: 771.823k

Closed: Mar 24, 2023

Hollow Logo Score: -2.540
BioMarin Pharmaceutical Inc. Stock
$90.74 (0.699%)

Volume: 771.823k

Closed: Mar 24, 2023

Score Hollow Logo -2.540

BioMarin Pharmaceutical Inc. Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-03-02 - 2023-03-24 SELL -9.37
2023-03-01 - 2023-03-02 HOLD -0.86
2023-02-24 - 2023-03-01 SELL -1.06
2023-02-23 - 2023-02-24 HOLD -1.08
2023-02-22 - 2023-02-23 SELL 0.0582

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE